Skip to content
The Policy VaultThe Policy Vault

Thyquidity solutionMedica

pituitary thyrotropin (thyroid-stimulating hormone, TSH) suppression in the management of thyrotropin-dependent well-differentiated thyroid cancer

Preferred products

  • generic levothyroxine tablets
  • Ermeza solution

Initial criteria

  • Patient meets ONE of the following: has tried one Step 1 Product (generic levothyroxine tablets or brands such as Synthroid or Levoxyl) OR is unable to swallow or has difficulty swallowing tablets
  • AND patient has tried the Step 2 Product (Ermeza solution)

Approval duration

1 year